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Abstract
Background: Gastrointestinal (GI) disease is one of the leading aetiologies of chest pain in a
primary care setting. The aims of the study are to describe clinical characteristics of GI disease
causing chest pain and to provide criteria for clinical diagnosis.
Methods: We included 1212 consecutive patients with chest pain aged 35 years and older
attending 74 general practitioners (GPs). GPs recorded symptoms and findings of each patient and
provided follow up information. An independent interdisciplinary reference panel reviewed clinical
data of each patient and decided about the aetiology of chest pain. Multivariable regression analysis
was performed to identify clinical predictors that help to rule in or out the diagnosis of GI disease
and Gastroesophageal Reflux Disease (GERD).
Results: GI disease was diagnosed in 5.8% and GERD in 3.5% of all patients. Most patients
localised the pain retrosternal (71.8% for GI disease and 83.3% for GERD). Pain worse with food
intake and retrosternal pain radiation were associated positively with both GI disease and GERD;
retrosternal pain localisation, vomiting, burning pain, epigastric pain and an average pain episode <
1 hour were associated positively only with GI disease. Negative associations were found for
localized muscle tension (GI disease and GERD) and pain getting worse on exercise, breathing,
m o v e m e n ta n dp a i nl o c a t i o no nl e f ts i d e( o n l yG Id i s e a s e ) .
Conclusions: This study broadens the knowledge about the diagnostic accuracy of selected signs
and symptoms for GI disease and GERD and provides criteria for primary care practitioners in
rational diagnosis.
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Chest pain is a common complaint in primary care 20 to
40% of the population will visit their GP for chest pain
during their lifetime [1]. While incidence varies according
to setting, country and inclusion criteria [2-4], there is a
similar range of different diseases that can cause chest
pain in a primary care setting [5,6]. Gastrointestinal (GI)
aetiologies have been quoted with frequencies of 8%-17%
and constitute an important aetiology for chest pain
encountered by the General Practitioner (GP) [3-7].
GPs face the challenge to diagnose serious cardiac
disease reliably but also to identify other causes
including appropriate testing and treatment.
There is still a lack of data on the presentation of GI
disease in chest pain patients derived from larger
samples in a primary care setting. Our prospective
study aims to describe the distinctive clinical character-
istics of GI disease and Gastroesophageal Reflux Disease
(GERD) and to give support for rational diagnosis in a
primary care setting.
Methods
We conducted a cross-sectional diagnostic study with a
delayed-type reference standard in a primary care setting
[8]. The final diagnosis was established by an expert
panel after 6 months of follow up. The aim of the initial
study was to investigate the diagnostic accuracy of signs
and symptoms for chest pain patients with Coronary
H e a r tD i s e a s e( C H D ) .I nt h i sa r t i c l ew er e p o r tr e s u l t so fa
secondary analysis in regards to the accuracy of clinical
criteria for GI disease and GERD.
Participating GPs and patients
We approached 209 GPs in the State of Hesse of whom
35.4% agreed to participate in the study. Only GPs being
prepared to undergo random recruitment quality con-
trols could take part. Participating practices had to recruit
consecutively every attending patient who had chest pain
either as presenting complaint or on questioning. The
recruitment period lasted 12 weeks for each practice. For
logistical reasons recruitment was staggered in four
waves between October 2005 and July 2006.
Every patient above 35 years with pain localized in the
area between clavicles and lower costal margins and
anterior to the posterior axillary lines was to be included.
Doctors were also asked to recruit at home visits and
emergency calls. Patients were eligible irrespective of the
acute or chronic nature of their complaint, or of
previously known conditions including Coronary Heart
Disease (CHD) or related risk factors. However, patients
whose chest pain had subsided for more than one month,
whose current episode of chest pain had been already
investigated resulting in a definite diagnosis and/or who
came for follow-up investigations for chest pain (e.g. an
orthopaedic doctor had already established a diagnosis
and the GPs continues the treatment) were excluded. In
emergency situations without sufficient time for patient
information and written consent, relevant clinical items
were documented on acase reportform (CRF) kept by the
GPs. Later, e.g. after discharge from hospital, the patient
was asked to participate in the study. Only if he gave
informed consent the CRF was handed over to study
personnel. Like the whole study protocol, this procedure
was approved by the Ethics Committee of the Faculty of
Medicine, University of Marburg. The study complies
with the declaration of Helsinki.
Data collection
GPs took a standardized history and performed a
physical examination according to a CRF that was
piloted and modified accordingly. We chose determi-
nants based on results of qualitative interviews con-
ducted with GPs on how they diagnose chest pain. The
CRF contained items about patient (e.g. patients known
to the GP, patient different as usual) and pain
characteristics (time, duration, location and radiation),
accompanying symptoms (e.g. dyspnoea, cough, vomit-
ing), risk factors for CHD, results of a basic physical
examination and the GP’s presumed diagnosis. GPs also
recorded their preliminary diagnoses, investigations and
management related to the patients’ chest pains. Patients
were contacted by phone six weeks and six months after
the index consultation. Study assistants blinded to
clinical data that already had been recorded asked
about the course of their chest pain, treatments including
hospitalisations and drugs. Discharge letters from
specialists and hospitals were requested from GPs.
Precautions against bias
Participating practices were recruited from a network of
research practices associated with our department. To GPs
we emphasized the importance of recruiting every patient
with chest pain, irrespective of the presumed likelihood of
CHD. Practices were visited at four week intervals to check
CRFs, recruitment logs and compliance with study
procedures. Random quality controls were performed by
searching routine documentation of participating practices
to identify cases of chest pain not included in the study.
Reference standard
A reference panel consisting of one cardiologist, one GP
and one research staff of the department of Family
Medicine reviewed baseline and follow up data of each
patient. As far as possible the definition and diagnostic
recommendations of the guideline “Reflux” of the
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taken into account. However, investigations as suggested
by the guideline were often not performed by GPs.
Therefore, data available to the reference panel were
often limited. Apparently the diagnosis of GERD was
made on the basis of the history alone. Our ‘delayed-
type reference standard’ may provide some reassurance
against alternative causes, e.g. peptic ulcer or carcinoma,
of participating patients’ complaints. The GP’si n i t i a l
diagnosis contributed to the decision made by the panel.
Statistical analysis
Our main analysis for distinctive clinical characteristics
associatedwithGIdiseaseandGERDisbasedonthesample
ofallpatientswithchestpainwherediagnosticclassification
was possible. For univariate analyses we calculated sepa-
rately for GI disease and GERD diagnostic odds ratios (OR)
for all items covered by the CRF. To arrive at a small subset
of criteria for clinical recommendation we selected those
index test items that had a p-value < 0.05 and ORs
indicating at least moderate diagnostic accuracy, i.e. OR+/-
>2 or <0.5 (univariate analysis). Those were included as
predictive variables in multivariate logistic regression
analysis. The outcome variables were GI disease and
GERD. Variable selection was conducted using the back-
ward stepwise procedure (p < 0.05). Odds ratio and 95%-
confidence intervals were calculated. All analyses were
performed with SPSS software version 14.0.
Results
GP and general patient characteristics
The majority of participatin gG P sw e r em a l e( 6 7 % ) ,t w o
thirds of practices were located in urban areas (63.5%).
Mean age of GPs was 49 years. According to our estimate
these 74 GPs encountered around 190.000 patients
during the study period and approached 1355 patients
with chest pain. 7 patients did not meet the inclusion
criteria after review of patient records by the study
investigators and were consequently excluded; 99
refused to participate in the study. 60 cases were lost to
follow up and 11 died but provided enough information
to be judged by the reference committee; 3 cases were
early drop outs and were therefore not included. For 34
cases follow-up information was lacking, incomplete or
ambiguous so that no final diagnosis could be made. We
thus analysed 1212 patients for the aetiology of their
chest pain; of these 71 were diagnosed as having GI
disease including 42 patients with GERD (figure 1).
The prevalence of chest pain during the study period was
0.7% (CI: 0.66-0.73) of all patient contacts. Major
diagnostic groups were: GI disease 5.8% (95% CI:
4.5% - 7.1%), Chest Wall Syndrome 46.6% (95% CI:
43.8% - 49.4%), Ischemic Heart Disease (stable) 11.1%
(95% CI: 9.4% - 12.8%), psychogenic disorders 9.5%
(95% CI: 7.9% - 11.3%) and upper respiratory infections
8.1% (95% CI: 6.6% - 9.8%).
Gastroesophageal reflux disease (GERD) alone contrib-
uted with 3.5% (95% CI: 2.6% - 4.7%) (n = 42), benign
stomach problems with 2.1% (95% CI: 1.5% - 3.1%)
(n = 26) and diseases of the biliary tract with 0.3%
(CI: 0.1% - 0.7%) (n = 3) to the aetiology of chest pain.
Compared with CHD patients, patients with GI disease
and GERD tend to have a lower mean age and a higher
proportion of females. While around half of the patients
with GI disease had chestpain atthe timeofconsultation,
this was only the case with one third of CHD and GERD
patients. In comparison to the other 2 groups, patients
with GERD were presenting in a lower proportion with
acute, i.e. duration <48 hours, chest pain (table 1).
Clinical characteristics
26.8% of patients with GI disease and 19.0% with GERD
complained of vomiting. In 21.1% (GI disease) and
21.4% (GERD) pain was worse with food intake. 49.3%
of patients with GI disease and 51.2% with GERD
thought that their chest pain would be of cardiac origin.
For GI disease pain was localised retrosternal in 71.8%
(60.5%-80.9%), epigastric in 29.6% (20.2%-41.0%), left
in 32.45 (22.7%-43.9%) and right in 23.9% (15.55-
35.0%). For GERD retrosternal location was 83.3%
(69.4%-91.7%) and epigastric location was 19.2%
(10.0%-33.3%).
The majority of patients reported a pain frequency of
more than one episode per day (58.2% (46.3%-69.3%)
Figure 1
Patient recruitment.
International Archives of Medicine 2009, 2:40 http://www.intarchmed.com/content/2/1/40
Page 3 of 7
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character was perceived by most patients as either
pressing (40.8% (30.2%-52.5%) for GI disease, 35.7%
(23.0%-50.8%) for GERD) or burning (29.6% (20.2%-
41.0%) for GI disease, 30.9% (19.1%-46.0%) for
GERD). Pain characteristics are listed in figure 2.
Follow up of patients with GI disease and GERD
71.8% of patients with GI disease and 71.4% of patients
with GERD still complained of chest pain when
contacted after 6 weeks by telephone. After a follow up
period of 6 months these numbers were reduced to
47.9% and 52.4% respectively. 74.6% of patients with GI
disease and 85.7% of patients with GERD continued to
consult their GP during the follow up period related to
the initial problem of chest pain.
Univariate and multivariate analysis
15 items (listed in the footnote of table 2) fulfilled our
univariate selection criteria for GI disease and GERD and
were selected for multivariable analysis the results of
which are reported in table 2.
Pain worse with food intake and retrosternal pain
radiation were associated positively with both GI disease
and GERD. Retrosternal pain localisation, vomiting,
burning pain, epigastric pain and an average pain
episode < 1 hour were associated positively with GI
disease. Negative associations were found for localized
muscle tension (GI disease and GERD) and pain
depending on exercise, pain worse with breathing or
movement, pain on the left side (GI disease).
In table 3 we present for clinical use diagnostic items
that were significant in the multivariable analysis with
corresponding likelihood ratios (LR). These can help to
rule in or to rule out GI disease and GERD [9].
Discussion
Among patients presenting with chest pain in general
practice, GI disease is with 5.8% (including 3.5% GERD)
the fifth common aetiology. Pain worse with food intake
and retrosternal pain radiation were associated positively
Table 1: Basic characteristics of CHD patients, patients presenting with GI disease including GERD and with GERD
Basic characteristics Patients with
CHD (n = 180)
Patients with GI
disease (n = 71)
Patients with
GERD (n = 42)
Mean age
(range)
69 years
(35 - 91 years)
58 years
(35 - 86 years)
58 years
(35 -86 years)
Sex - female patients - n (%) 88 (48.9) 47 (66.2) 25 (59.5)
Chest pain at the time of consultation - n (%) 56 (31.1)* 33 (47.1)* 15 (35.7)*
Known by the GP - n (%) 167 (92.8) 65 (91.5) 39 (92.9)
Chest pain as reason for consultation - n (%) 149 (82.8) 64 (90.1) 37 (88.1)
Acute chest pain (< 48 hours) - n (%) 51 (28.3)* 19 (27.9)* 7 (16.7)*
*Slightly changing denominator because of missing data.
Figure 2
Pain localisation, frequency and character of patients
presenting with GI disease (n = 71) and with GERD
(n = 42).
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localisation, vomiting, burning pain, epigastric pain
and an average pain episode < 1 hour were associated
p o s i t i v e l yo n l yw i t hG Id i s e a s e .
There are strengths and limitations to this study. To our
knowledge this is the largest study investigating the
epidemiology and aetiology of chest pain in primary
care. Patients were consecutively recruited in a large
Table 2: Clinical characteristics associated with GI disease (including GERD) and with GERD (multivariable model, n = 1212)
Index test Unadjusted OR
(95%-CI)
adjusted OR
(95%-CI)
pv a l u e
Association with GI disease
Burning pain 3.30 (1.92-5.67) 3.16 (1.53-6.49) <0.01
Vomiting, 5.59 (3.14-9.97) 8.01 (3.80-16.85) <0.01
Pain worse with food intake 18.83 (8.86-40.02) 31.27 (8.82-110.82) <0.01
Retrosternal pain localisation 1.95 (1.15-3.32) 2.37 (1.10-5.10) 0.03
Epigastric pain localisation 2.48 (1.45-4.25) 3.48 (1.63-7.46) <0.01
Retrosternal pain radiation 6.68 (3.51-12.72) 5.02 (1.90-13.25) <0.01
Average pain episode < 1 hour 2.34 (1.36-4.02) 3.30 (1.57-6.91) <0.01
Pain worse with movement 0.22 (0.10-0.52) 0.36 (0.14-0.94) 0.04
Pain depending on exercise 0.21 (0.08-0.57) 0.15 (0.04-0.58) <0.01
Localised muscle tension 0.45 (0.26-0.80) 0.44 (0.22-0.90) 0.03
Pain worse with breathing 0.21 (0.07-0.57) 0.33 (0.11-0.99) 0.05
Pain on the left side 0.25 (0.15-0.42) 0.42 (0.22-0.81) 0.01
Association with GERD
Pain worse with food intake 14.23 (6.09-33.27) 16.49 (4.39-61.99) <0.01
Retrosternal pain localisation 3.83 (1.69-8.71) 3.18 (0.98-10.32) 0.05
Retrosternal pain radiation 8.29 (3.93-17.49) 6.32 (2.21-18.06) <0.01
Pain on the left side 0.19 (0.10-0.39) 0.40 (0.14-1.11) 0.08
Localised muscle tension 0.25 (0.10-0.61) 0.35 (0.13-0.94) 0.04
For GI disease the following variables were selected for multivariable analysis (according to performance markers in univariate analysis: p < 0.05;
OR >2 or <0.5): burning pain, vomiting, pain worse with ingestion, retrosternal pain localisation, epigastric pain localisation, pain on the left
side, retrosternal pain radiation, average pain episode < 1 hour, average pain episode < 1 minute, pain worse with movement, pain depending on
exercise, stinging pain, localized muscle tension, patient dyspnoeic, pain worse with breathing.
For GERD the following variables were selected for multivariable analysis (according to performance markers in univariate analysis: p < 0.05; OR >2
or <0.5): burning pain, vomiting, pain worse with ingestion, retrosternal pain localisation, pain on the left side, retrosternal pain radiation, continuous
pain, average pain episode < 1 hour, pain worse with movement, pain depending on exercise, stinging pain, localized muscle tension, pain worse
with breathing, pain at the time of consultation, pain reproduced by palpation.
Table 3: Clinical recommendation
Useful for including disease LR + Useful for excluding disease LR +
GI disease
Pain worse with food intake 21.00 Pain depending on exercise 0.27
Vomiting 4.50 Pain worse with breathing 0.27
Retrosternal pain 5.25 Pain worse with movement 0.29
GERD
Pain worse with food intake 10.5 Localized muscle tension 0.38
Retrosternal pain radiation 6.39
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GPs’ demographic characteristics are similar to the
population of GPs in the State of Hesse (data available
upon request). Study procedures, including random
quality controls, reduced the possibility of selection bias.
We did not interfere with the work-up provided by
participating GPs. As a result of this, only limited data of
GI investigations were available to the reference panel.
Given the difficulty in organising research in general
practice settings, we consider our design as appropriate.
Due to the broad range of diseases that can cause chest
pain we could not standardise case definitions for all
single diseases. Case definition of GI and GERD is based
on clinical findings and the GP’s presumed diagnosis
and was not systematically investigated by a gastroscopy.
Therefore misclassifications cannot be excluded. How-
ever, existing guidelines were used as much as possible
and planning a delayed diagnosis improved the accuracy
of the reported diagnosis.
As clinical findings and the GP’sp r e s u m e dd i a g n o s i s
(data from the original questionnaire) were also used by
the panel for decision making there is a certain degree of
incorporation bias.
Other studies conducted in a primary care setting quote
higher frequencies of GI aetiologies (8%-17%) for chest
pain [3-6]. One possible explanation is different inclu-
sion/exclusion criteria. A Swedish study group excluded
all patients with known CHD; a higher relative aetiolo-
gical contribution of other diseases might have resulted
from this exclusion [3]. Work up bias and different
reference standards might be an additional explanation
as studies differed in the length of the follow up period
and the way a final diagnosis was decided on [5,7].
GPs think in the diagnostic work up process of patients
rather in pragmatic than in distinct aetiological disease
categories. We therefore analysed our data for two
reference parameters, GI disease (including GERD,
benign stomach disease, and diseases of the biliary
tract) and GERD alone. Predominant symptoms for
GERD are heartburn, a burning pain situated in the
retrosternal area, and regurgitation of gastric acid
[10-13]. In our study one third of GERD patients
complained of burning pain and 72% localised the
pain in the retrosternal region.
There are only few studies in regards to the diagnostic
utility of reflux disease symptoms [14]. Two studies
conducted in a different setting (gastroenterological
clinic) examined in a consecutive and prospective study
design diagnostic characteristics of selected symptoms
for GERD in patients with non-cardiac chest pain
[15,16]. Burning pain showed a sensitivity of 57% and
positive LR of 2.7[16] which is in line with our findings
for GI disease (positive LR of 2.7). However, in our
sample burning pain did not discriminate significantly
for GERD alone. Davies et al. examined patients with
acute chest pain in an emergency setting for oesophageal
aetiologies. They found positive LRs of 10.1 for ‘pain
triggered by ingestion’, 3.7 for heartburn, 2.0 for
vomiting and 1.2 for retrosternal pain localisation [17].
We also found all above mentioned symptoms being of
significant diagnostic accuracy for GI disease and partly
for GERD.
When encountering patients with chest pain, the GP
faces the problem that single symptoms might not yield
enough diagnostic information to base a sound decision
on. The clinician therefore has to combine different
clinical symptoms and signs [18]. Whereas in our study
single likelihood ratios for each sign and symptom were
at best moderate, they contribute to rule in or out GI
disease or GERD when applied in succession [9]. A
positive proton pump inhibitor (PPI) test (at least 50%
clinical improvement after prescription of a high dosed
PPI for 2-4 weeks) can be an additional aid for the
diagnosis of GERD. However, two metaanalyses showed
only moderate sensitivity (80%) and specificity (74%)
for patients with non-cardiac chest pain[19,20] and these
results have to be interpreted with caution when
considering to apply them for a primary care population.
Conclusions
In conclusion, GI disease including GERD is the fifth
most frequent cause of chest pain in primary care. This
study provides data on the diagnostic accuracy of
selected signs and symptoms which will help primary
care practitioners to narrow the likelihood of GI disease.
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